Marco Weiergraber

My research group "Experimental Neuropsychopharmacology" analyses brain rhythmicity in animal models of Alzheimer's disease. We are mainly interested in neuronal network dysfunction and how CNS-related drugs can modulate or restore neuronal malcommunication. A specific focus is on the characterisation of EEG biomarkers / EEG fingerprints in Alzheimer's disease. The methodological focus is on radiotelemetry, MEA, ERPs, behavioral/ cognition tests and complex time-frequency analysis.